<DOC>
	<DOCNO>NCT00540384</DOCNO>
	<brief_summary>The purpose study assess safety NESP administer SC injection subject solid tumour anaemia receive multicycle chemotherapy . Subjects study enter one two schedule : Schedule 1 Schedule 2 . Schedule 1 sequential dose escalation study consist Parts A B . Part A initial treatment phase , clinically effective dose ( CED ) NESP administer every 3 week determine 12 week treatment . Part B optional 12-week , open-label , dose-maintenance phase follow Part A . Schedule 2 parallel dose-finding study also consist Parts A B . Part A initial treatment phase , CED NESP administer every 4 week determine 12 week treatment . Part B optional 12-week , open-label , dose-maintenance phase follow Part A .</brief_summary>
	<brief_title>Dose-finding Study Novel Erythropoiesis Stimulating Protein ( NESP ) Treatment Anaemia Subjects With Solid Tumours Receiving Multicycle Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Subject solid tumour ( ) Anaemia ( hgb less equal 11.0 g/dL Planned receive cyclic chemotherapy At least 6month life expectancy Eastern Cooperative Oncology Group ( ECOG ) status 0 2 Adequate renal liver function At least 18 year age Central nervous system disease Iron deficiency Received 2 RBC transfusion within 4 week randomisation RBC transfusion within 2 week randomisation Received recombinant human erythropoietin ( rHuEPO ) therapy within 8 week randomisation History seizure disorder Cardiac disease Active infection inflammatory disease Known positive test HIV infection Known primary haematologic disorder could cause anaemia Use investigational agent ( ) /device ( ) Pregnant breast feed Known hypersensitivity recombinant mammalian derive product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Solid tumor</keyword>
	<keyword>Multicycle chemotherapy</keyword>
	<keyword>NESP</keyword>
</DOC>